AstraZeneca makes deal with White House to lower drug prices

AstraZeneca became the second drugmaker to enter a deal with the Trump administration to offer lower prices to Medicaid and to offer some of its drugs at a discount through TrumpRx, a government website to facilitate sales directly to consumers.

“In other words the lowest price anywhere in the world, that’s what we get,” President Trump said during an Oval Office press conference Friday. The centerpiece of the deal is most-favored-nation pricing for drugs sold to Medicaid. That would link Medicaid prices to the lower ones paid in other developed countries.

As part of the deal, AstraZeneca will also offer discounts of up to 80% off list prices on direct sales to consumers, according to a company statement. Its drugs include inhalers like Bevespi Aerosphere for people with COPD and Airsupra for people with asthma. AstraZeneca, based in the U.K., also said it would expand drug manufacturing and research in the U.S.

In return for these commitments, the drug company will get a three-year exemption from certain tariffs.

The White House unveiled its plan for TrumpRx and a similar deal with Pfizer on Sept. 30. The website will help patients access drugs at lower prices — bypassing health insurance.

TrumpRx is part of a broader initiative the administration says is aimed at bringing prices paid by Americans more in line with those paid in other developed countries.

The announcement follows an executive order in May, and letters to 17 pharmaceutical companies sent out over the summer to push them to lower prices voluntarily.

The TrumpRx website is expected to launch sometime in 2026, and would take consumers to pharmaceutical companies’ direct-to-consumer websites to fulfill orders.

The impact of the Trump administration deals with pharmaceutical companies for consumers is unclear. Medicaid and its beneficiaries, for instance, already pay some of the lowest prices for drugs. And people with health insurance could spend less on their medicines through copays than buying them directly from AstraZeneca.

AstraZeneca also said Thursday that it would invest an additional $500 million in a new manufacturing facility in Virginia, raising the investment to $4.5 billion. That’s part of a $50 billion investment announced in July to expand manufacturing facilities in California, Indiana, Maryland, Massachusetts, Texas and Virginia, as well as other research and development efforts.

“For all the pharmaceutical companies out there — we’re talking to all of you, pick up a shovel,” said Dr. Mehmet Oz, who leads the Centers for Medicare and Medicaid Services, during the press conference.

Trump said his administration had gotten a total of $18 trillion total commitments to re-shore pharmaceutical manufacturing. NPR wasn’t immediately able to independently confirm that number.

 

FBI Deputy Director Dan Bongino says he will step down in January

Bongino's tenure was at times tumultuous, including a clash with Justice Department leadership over the Epstein files. But it also involved the arrest of a suspect in the Jan. 6 pipe bomber case.

Federal court says troops can stay in D.C., and hints at prolonged deployment

A federal appeals court in Washington, D.C. has ruled that National Guard troops can remain in the city for now. That decision comes after a different federal appeals court ruled that troops must leave Los Angeles earlier this week.

Jack Smith defends his prosecutions of Trump in closed-door session in Congress

The former Justice Department special counsel told the House Judiciary Committee that his team developed "proof beyond a reasonable doubt" that Trump took part in a criminal scheme to overturn the 2020 election.

A Chinese man who filmed secret footage in Xinjiang risks deportation from the U.S.

Guan Heng sailed to the U.S. by boat from the Bahamas after publishing footage he filmed of purported detention camps in China. He has been held in immigration detention since August.

‘Harry Potter’ fans are flying to Broadway to see the original Draco Malfoy

Almost eight years after Harry Potter and the Cursed Child opened on Broadway, Tom Felton, who played Draco Malfoy in the films, is now playing him as an adult onstage.

A photographer discovers miles of dinosaur tracks near Italy’s Winter Olympic venues

A nature photographer stumbled upon thousands of 210-million-year-old dinosaur tracks in Italy's central Alps, near where some Olympic skiing and snowboarding events will be held in February.

More Front Page Coverage